Clinical Trial Update: Paclitaxel,Cyclophosphamide and Dexamethasone for Relapsed or Refractory Multiple Myeloma [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating Paclitaxel, Cyclophosphamide, and Dexamethasone for relapsed or refractory multiple myeloma has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• DEXAMETHASONE (Dexamethasone)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Relapse/Refractory Multiple Myeloma | Phase 2 | Status: WITHDRAWN